Connell Consulting
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
EQT to buy BSN Medical for €1.8 billion

Private equity fund EQT VI has agreed to buy medical device manufacturer BSN Medical from Montagu Private Equity for €1.8 billion (£1.4 billion).

BSN has annual sales of €700 million and around 4,000 employees. It is a major supplier of wound care, compression therapy and orthopaedic products to hospitals and pharmacies around the world.

The company was founded in 2001 as a joint venture between Beiersdorf AG and Smith & Nephew, and was acquired by Montagu Private Equity in 2005.

“We view BSN as a highly attractive growth case with strong resilience across the business cycle,” said Marcus Brennecke, partner at EQT Partners in Germany, and investment advisor to EQT VI.

“While continuing to strengthen the position in key markets and in key product segments, there is tremendous potential in entering new geographic markets, especially in Asia and Latin America. BSN’s global foot-print and large sales force provide an excellent platform for add-on acquisitions.”

BSN’s chief executive, Claus-H Wiegel, said: “We will look forward to working with EQT to deliver the next phase of BSN’s growth story.”

The transaction is subject to regulatory clearances. Morgan Stanley and Deutsche Bank acted as financial advisors to EQT VI. Goldman Sachs and HSBC acted as financial advisors to Montagu and BSN.

Posted on: 11/06/2012

Latest news stories

26/06/2017
A new partnership between an acute trust, a GP-owned provider and a private company has been awarded a £48 million, five-year contract for out-of-hours GP and NHS 111 services in Cornwall.
23/06/2017
Duke Street-backed Voyage Care is in exclusivity to buy Focus Care Agency, a domiciliary care provider, HealthInvestor UK understands.
23/06/2017
AnimalCare, a UK-based supplier of veterinary medicine and products, is set to acquire Ecuphar, a larger firm based in Europe, in a reverse takeover.
22/06/2017
The Democratic Unionist Party has requested an additional £1 billion for the NHS in Northern Ireland, according to sources speaking to the BBC.
22/06/2017
London-listed Assura has raised £98.4 million in gross proceeds through an oversubscribed placing.


HealthInvestor Events


children's services special report
- part 2

Success at Witherslack Group has been driven by a focus on high acuity cases and a substantial support structure for teachers, finds Ploy Radford
Read more



politics
Believe the polls, and June's election will spell more of the same, with a renewed Tory majority bringing few changes for health and care. The polls, though, have much to prove. Sarah Williams weighs up what the different parties' pledges could mean...
Read more


Christie + Co


company profile - Huntercombe Group

The Huntercombe Group is going through a transformation, and is allegedly being sold to ease Four Seasons' unwieldy debt levels. Ploy Radford asks CEO Valerie Michie if the business is shaking off the past
Read more





interview - Avnish Goyal

Avnish Goyal, managing director of Hallmark Care Homes and chair of Care England, talks to Ploy Radford about building a successful care business, the perils of sale and leaseback and what the future holds for the care sector
Read more



HealthInvestor blog
The Competition & Markets Authority has held a mirror up to the sector and it’s not comfortable viewing

Click here to view the Editor's blog


Chairman and non-executive director for various care sector-related companies, partner at private equity fund Duke Street and a keen musician
Dr Stewart Southey and Marc Kitten of Candesic review the latest applications of blockchain technology to healthcare and life sciences
Is supported living always the best option? Clare Connell and Charlotte Bushnell of Connell Consulting investigate
The Huntercombe Group is going through a transformation, and is allegedly being sold to ease Four Seasons’ unwieldy debt levels. Ploy Radford asks CEO Valerie Michie if the business is shaking off the past
As Circle exits the London Stock Exchange, Nick Herbert investigates the host of factors that determine whether a company should remain public or go private

Click here to search all feature articles












Search news
and features



Go






Christie + Co